Nimbus Therapeutics Appoints Peter J. Tummino, Ph.D. As President of Research and Development
Jan 09, 2025•11 months ago
Position
President
Company
Nimbus Therapeutics
Description
Nimbus Therapeutics announced the advancement of its clinical oncology therapeutic pipeline and the appointment of Peter J. Tummino, Ph.D., to President of Research and Development.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months